$ABVC

$1.06 +$0.02 (1.92%) Live

$ABVC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 26.7M shares outstanding

Who owns ABVC?

By type of holder

Institutions 4.1% Everyone else 95.9%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 4.4%

Vanguard Capital Management LLC 1.4% · Geode Capital Management, LLC 0.9%

Institutional ownership

4.1%

+1.0 pts vs last qtr

Institutional holders

+2 vs last qtr

Net shares bought

+273.3K

by institutions in Q2 2026

New / sold out

7 / 5

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Vanguard Capital Management LLC +183.9K
Citadel Advisors LLC NEW +72.1K

Biggest sellers in Q2 2026

Renaissance Technologies LLC SOLD OUT −95.1K
Two Sigma Securities, LLC SOLD OUT −21.0K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for ABVC Biopharma Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025

+895.2%

+33.27% a year

Each share's claim on the business

−90.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $24.2M

over 9 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years75% Under 1 year25%

Quarterly turnover

34.4%

of institutional shares changed hands

Top 10 managers, median time held

2 years

Super Investors

Investment managers reporting ABVC on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
VC Vanguard Capital Management LLC	374.5K	1.41%	+183.9K (+96.5%)	2023	0.0%
Shares held by quarter Peak holding374.5K (Q2'26) Change over 8 quarters+374.5K Share of the company1.410% Vanguard Capital Management LLC's full portfolio →
GC Geode Capital Management, LLC	228.0K	0.86%	+6.9K (+3.1%)	2023	0.0%
Shares held by quarter Peak holding228.0K (Q2'26) Change over 8 quarters+156.4K Share of the company0.860% Geode Capital Management, LLC's full portfolio →

Vanguard Capital Management LLC

374.5K

% of company

1.41%

Change vs last qtr

+183.9K (+96.5%)

Held since

2023

Geode Capital Management, LLC

228.0K

% of company

0.86%

Change vs last qtr

+6.9K (+3.1%)

Held since

2023

18 more super investors behind a free account

See every manager holding ABVC Biopharma Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ABVC on Form N-PORT; together they hold 1.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$329K	208.3K	0.78%	0.00%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$182K	115.2K	0.43%	0.00%	June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$329K

% of company

0.78%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$182K

% of company

0.43%

% of the fund

0.00%

As of

June 30, 2026

5 more funds behind a free account

See every fund holding ABVC Biopharma Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
EJ Eugene Jiang 5%+ holder 13D · 18.5%	131.2K	0.49%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company0.490% Disclosed stake13D · 18.5% View the 13D/G filing →

Eugene Jiang

5%+ holder13D · 18.5%

131.2K

% of company

0.49%

Change vs last qtr

—

Held since

—

Comments